RECRUITING

Preimplantation Genetic Testing in Women of Advanced Maternal Age

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

Official Title

GEnetic Testing in Elective Single Embryo Transfer in Women of Advanced Maternal Age

Quick Facts

Study Start:2021-03-05
Study Completion:2024-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04167748

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:35 Years to 40 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Women undergoing IVF of between 35 and 40 years of age at IVF cycle start
  2. * Utilization of Intracytoplasmic Sperm Injection ICSI
  3. * Utilization of ejaculated or testicular sperm
  4. * Utilization of autologous or donor sperm
  5. * All Controlled Ovarian Hyperstimulation (COH) protocols
  1. * Patients with anovulatory Polycystic ovarian syndrome (PCOS)
  2. * Utilization of donor oocytes
  3. * Utilization of gestational carrier
  4. * Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages
  5. * Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers

Contacts and Locations

Study Contact

Nathan R Treff, PhD
CONTACT
(973) 529-4223
nathan@genomicprediction.com
Diego Marin, PhD
CONTACT
(973) 529-4223
diego@genomicprediction.com

Principal Investigator

Nathan R Treff, PhD
PRINCIPAL_INVESTIGATOR
Genomic Prediction

Study Locations (Sites)

IVF Florida Reproductive Associates
Margate, Florida, 33063
United States

Collaborators and Investigators

Sponsor: Genomic Prediction Inc.

  • Nathan R Treff, PhD, PRINCIPAL_INVESTIGATOR, Genomic Prediction

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-03-05
Study Completion Date2024-12

Study Record Updates

Study Start Date2021-03-05
Study Completion Date2024-12

Terms related to this study

Additional Relevant MeSH Terms

  • Infertility, Female